Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Caffeine and Vyvanse Concurrent Use in ADHD

Key Clinical Considerations

  • The American College of Cardiology/American Heart Association guidelines recommend limiting caffeine intake to less than 300 mg daily and avoiding use in patients with uncontrolled hypertension, when used with amphetamines like Vyvanse, due to potential additive cardiovascular effects 1
  • The American Academy of Child and Adolescent Psychiatry does not identify caffeine as a contraindication to stimulant medications for ADHD, but recommends cautious use 2

Cardiovascular Monitoring

  • Monitor blood pressure and heart rate when combining caffeine and Vyvanse, as both can cause acute increases in blood pressure, according to the American Heart Association 1
  • Amphetamines should be avoided in patients with uncontrolled hypertension, underlying coronary artery disease, and tachyarrhythmias, as recommended by the National Comprehensive Cancer Network 3

Practical Management Algorithm

  • Start Vyvanse at 20-30 mg once daily in the morning, with weekly titration by 10 mg increments up to a maximum of 70 mg daily, and limit caffeine to less than 300 mg daily, as recommended by the American Journal of Obstetrics and Gynecology 4, 5
  • Administer both substances early in the day to minimize sleep disturbances, and avoid caffeine after 4:00 pm to prevent insomnia, as recommended by the National Comprehensive Cancer Network 6

Monitoring Parameters

  • Check blood pressure and heart rate at each dose adjustment and regularly during maintenance therapy, and monitor for anxiety, agitation, insomnia, tremor, palpitations, and headache, as recommended by the American College of Cardiology and the National Comprehensive Cancer Network 1, 3, 7

Special Populations

  • Reduce or eliminate caffeine intake in patients with uncontrolled hypertension, coronary artery disease, or arrhythmias, and consider alternative ADHD treatments such as atomoxetine or guanfacine in high-risk cardiovascular patients, as recommended by the American College of Cardiology and the American Journal of Obstetrics and Gynecology 1, 3, 4
  • Monitor closely for increased anxiety symptoms when initiating Vyvanse in caffeine users, especially in patients with pre-existing anxiety disorders, as recommended by the American Academy of Child and Adolescent Psychiatry 2
  • If insomnia develops, eliminate afternoon caffeine consumption first, and consider reducing Vyvanse dose or switching to shorter-acting formulations if sleep problems persist, as recommended by the National Comprehensive Cancer Network 6